Drupal.behaviors.print = function(context) {window.print();window.close();}>
HTG Licenses Merck's Breast Cancer Biomarker Patent Portfolio
July 11, 2012
HTG Licenses Merck's Breast Cancer Biomarker Patent Portfolio
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Adaptive Bio, Bristol-Myers Squibb Collaborate on Cancer Biomarkers
May 9, 2013 / GenomeWeb Daily News
Oxford Cancer Biomarkers Developing CDx Biomarkers for AstraZeneca
April 16, 2013 / GenomeWeb Daily News
AnalizaDx, GHMI Partner to Bring Cancer Dx to Africa, the Caribbean
February 27, 2013 / GenomeWeb Daily News
OGT Inks Deal with CCMC to Build Cancer Microarray
February 26, 2013 / GenomeWeb Daily News
VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 3, 2012 / GenomeWeb Daily News